Medtronic (NYSE: MDT) reported Q3 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $6.93 billion versus the consensus estimate of $6.99 billion.

GUIDANCE:

Medtronic still sees FY16 EPS of $4.36 - $4.40, versus the consensus of $4.38.

For earnings history and earnings-related data on Medtronic (MDT) click here.